✦ LIBER ✦

Oral Versus Intravenous Melphalan and Prednisone Treatment in Multiple Myeloma Stage II: A randomized study from the Myeloma Group of Central Sweden

✍ Scribed by Österborg, A.; Åhre, A.; Björkholm, M.; Björeman, M.; Brenning, G.; Gahrton, G.; Grimfors, G.; Gyllenhammar, H.; Hast, R.; Johansson, B.; Juliusson, G.; Järnmark, M; Killander, A.; Kimby, E.; Lerner, R.; Nilsson, B.; Paul, C.; Simonsson, B.; Stalfelt, A.-M.; Smedmyr, B.; Svedmyr, E.; Udén, A.-M.; Wadman, B.; Ösby, E.; Mellstedt, H.

Book ID: 126565306
Publisher: Informa plc
Year: 1990
Tongue: English
Weight: 426 KB
Volume: 29
Category: Article
ISSN: 0284-186X
DOI: 10.3109/02841869009092991

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Addition of thalidomide to oral melphala

Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group

✍ Meral Beksac; Rauf Haznedar; Tulin Firatli-Tuglular; Hakan Ozdogu; Ismet Aydogdu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

Randomized comparison of dexamethasone c

Randomized comparison of dexamethasone combined with melphalan versus melphalan with prednisone in the treatment of elderly patients with multiple myeloma

✍ J. M. Hernández; R. García-Sanz; E. Golvano; J. Bladé; J. Fernandez-Calvo; J. Tr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Alternating combination chemotherapy (VM

Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III —A randomized study from MGCS

✍ A. Österborg; A. Ahre; M. Björkholm; M. Björeman; G. Brenning; G. Gahrton; H. Gy 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB

Use of the hypoxic cell sensitizer etani

Use of the hypoxic cell sensitizer etanidazole (SR-2508) with intravenous melphalan and prednisone in the treatment of multiple myeloma: A pharmacokinetic study

✍ Lawrence N. Shulman; Lori Buswell; Leslie A. Kalish; C. Norman Coleman 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 422 KB

High doses of natural α-interferon (α-IF

High doses of natural α-interferon (α-IFN) in the treatment of multiple myeloma — A pilot study from the Myeloma Group of Central Sweden (MGCS)

✍ A. Åhre; M. Björkholm; A. Österborg; G. Brenning; G. Gahrton; H. Gyllenhammar; G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

Comparison of melphalan and prednisone w

Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma : Results of Eastern Cooperative Oncology Group study E2479

✍ Martin M. Oken; David P. Harrington; Neil Abramson; Robert A. Kyle; William Knos 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## METHODS. Four hundred seventy-nine previously untreated patients with multiple myeloma from 23 ECOG institutions were enrolled. Treatment, assigned by ran-1 The Virginia Piper Cancer Institute and the Unidomization, consisted of either 4-week cycles of MP or 5-week cycles of VBCMP.